- Report
- September 2026
- 242 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- September 2026
- 221 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- September 2026
- 174 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- September 2026
- 220 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- September 2026
- 181 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- September 2026
- 181 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- September 2026
- 383 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- September 2026
- 187 Pages
Global
From €5320EUR$5,850USD£4,573GBP
- Report
- August 2026
- 145 Pages
Global
From €4319EUR$4,750USD£3,713GBP
- Report
- July 2026
- 120 Pages
Global
From €4319EUR$4,750USD£3,713GBP
- Report
- July 2026
- 185 Pages
Global
From €4319EUR$4,750USD£3,713GBP
- Report
- May 2026
- 140 Pages
Global
From €4319EUR$4,750USD£3,713GBP
- Report
- April 2026
- 70 Pages
Global
From €4319EUR$4,750USD£3,713GBP
- Report
- May 2026
- 148 Pages
Global
From €3592EUR$3,950USD£3,088GBP
- Report
- January 2026
- 140 Pages
Global
From €3592EUR$3,950USD£3,088GBP
- Report
- January 2026
- 128 Pages
Global
From €3592EUR$3,950USD£3,088GBP
- Report
- August 2026
- 160 Pages
Global
From €3019EUR$3,320USD£2,595GBP
€3774EUR$4,150USD£3,244GBP
- Report
- July 2026
- 160 Pages
Global
From €3019EUR$3,320USD£2,595GBP
€3774EUR$4,150USD£3,244GBP
- Report
- April 2026
- 160 Pages
Global
From €3019EUR$3,320USD£2,595GBP
€3774EUR$4,150USD£3,244GBP
- Report
- January 2026
- 160 Pages
Global
From €2873EUR$3,160USD£2,470GBP
€3592EUR$3,950USD£3,088GBP

The Guide RNA (gRNA) market is a subset of the genomics industry that focuses on the development and production of gRNA molecules. gRNA molecules are used in a variety of applications, including gene editing, gene regulation, and gene expression. gRNA molecules are composed of a guide sequence, which is complementary to a specific target sequence in the genome, and a scaffold sequence, which provides stability and specificity to the gRNA molecule.
The gRNA market is driven by the increasing demand for gene editing and gene regulation technologies, as well as the growing need for more efficient and cost-effective gene expression tools. Additionally, the development of new gRNA technologies, such as CRISPR-Cas9, has further increased the demand for gRNA molecules.
Some of the major companies in the gRNA market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, New England Biolabs, and OriGene Technologies. Show Less Read more